Biopharmaceutical industry has become a focus of multi-site development, the market size is growing

Pharmaceutical Network Industry Dynamics: Biopharmaceutical industry is one of China's strategic emerging industriesThe biopharmaceutical industry has the characteristics of high technology, high investment, high risk, high value added, long cycle, multi-disciplinary cross,in recent years, benefitfrom the policy advantage and many other factors, China's biopharmaceutical industry is developing very rapidly, the market scale is growing, China's biopharmaceutical industry park also developedIt is reported that in recent years, the development of biopharmaceutical industry has become the focus of many development
Guangzhou, Guangdong, proposed to build a new highland for the development of the global biopharmaceutical industryWe will fully implement the Regulations on Accelerating the Development of the Biopharmaceutical Industry in Guangzhou, and further enhance the level of synergy and comprehensive competitiveness of the entire industrial chain of biopharmaceutical technology research and development, clinical research, transformation, production and manufacturing, and medical materials
It states that leading enterprises should be encouraged to set up biopharmaceutical industry investment funds, guide other social capital to support the construction of new drugs, innovative medical device projects and biopharmaceutical industrial parks, and that projects to be invested in the approval and approval of drugs, drug supervision and management shall be included in the green channel and priority handled by the relevant departments of the city and the district
In addition, Guangdong also pointed out that in 2022, the realization of guangdong province's biopharmaceutical industry scale of more than 400 billion yuan, the cultivation of the main business income of more than 100 billion yuan of enterprises, more than 10 billion yuan of enterprises 10, more than 100 million enterprises, sales of more than one million yuan of a single variety of more than 1000
Shenzhen, Shenzhen, recently issued the "Shenzhen To Promote the Development of Biopharmaceutical Industry" and "Shenzhen Biopharmaceutical Industry Cluster Development Implementation Program (2020-2025)" "Shenzhen Biopharmaceutical Industry Development Action Plan (2020-2025)", proposed to optimize the space layout of the biopharmaceutical industry, to create a "one-core multi-center" characteristic development pattern
Its clear four key areas of common key technology breakthroughs, namely, antibody engineering, cell engineering, immunotherapy, gene therapy and other biomedical innovation, PET-MRI fusion technology, medical robots, gamma knife, proton heavy ion therapy and other high-end medical device research and development, BT-IT technology deep fusion, artificial life components, artificial life components and other advanced biological engineering technologyAt the same time, efforts are made to build ten major industrial support platforms, such as basic research and development innovation, transformation of scientific and technological achievements and professional service platform solely in the chain, to support innovation and development
In February, Xi'an issued the Action Plan for the Development of Biopharmaceutical Industry Clusters in Xi'an (2020-2022) and the Xi'an High-tech Zone's Policy on Supporting the Development of Biopharmaceutical Production Enterprises during the Prevention and Control of the New Corona pneumonia Outbreak, with the aim of speeding up the development of biopharmaceutical industry, helping to combat the epidemic and accelerating the restoration of regional economic and social order
As one of the key industries in Xi'an High-tech Zone, the biopharmaceutical industry has strong innovative momentum and remarkable development results, and has formed a regional industrial chain pattern based on innovation research and development, pharmaceutical manufacturing, medical service industry and pharmaceutical circulation
The Program focuses on the five key areas of "doing strong modern Chinese medicine, optimizing the medicine, making large biological medicine, making fine medical devices, doing special tourism", implementing the four major projects of "industrial foundation cultivation, industrial innovation transformation, industrial cooperation promotion, industrial digital transformation", and promotes the "eight one" key work, promotes the stock improvement transformation and incremental cultivation breakthrough, and makes every effort to build a national biopharmaceutical industry (high-end medical device) innovation base and service."
Xiamen Xiamen Science and Technology Bureau in accordance with the city's future industrial development direction, and combined with the current prevention and control needs of the new coronavirus pneumonia outbreak, accelerate the implementation of innovative driving development strategy, give full play to the support and leading role of science and technology in the development of the biopharmaceutical industry, support the "three high" enterprise development of the biopharmaceutical industry, quickly launch the 2020 biopharmaceutical field of major scientific and technological projects, arrange 48 million yuan, guide support for major public health, scientific and technological research and development and industrialization, Research and development and industrialization of generic and similar drugs, medical device research and development and industrialization, digital diagnostic equipment, development of marine living resources and high-value applications and other key technologies and industrialization